Marinus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.22-$10.50 |
Market Cap | $29.8M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $30.2M |
Revenue Growth (YoY) | 32.5% |
Gross Profit (12 Mos) | -$67.1M |
Diluted EPS | -$2.47 |
News
See moreYahoo Finance • last year
Marinus Pharmaceuticals to Present at the 6th Annual Evercore ISI HealthCONx Conference
Yahoo Finance • 2 years ago
Marinus Pharmaceuticals Further Strengthens Board of Directors with Appointment of Sarah Noonberg, M.D., Ph.D.
Yahoo Finance • 2 years ago
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
Yahoo Finance • 2 years ago
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Scott N. Braunstein M.D. |
CFO | Mr. Steven E. Pfanstiel C.M.A., M.B.A. |
Address | 5 Radnor Corporate Center, Radnor, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 165 |
